Literature DB >> 8701397

Factor VII gene polymorphisms, factor VII:C levels and features of insulin resistance in non-insulin-dependent diabetes mellitus.

D M Heywood1, M W Mansfield, P J Grant.   

Abstract

The macrovascular complications of non-insulin-dependent diabetes mellitus (NIDDM) are related to the features of insulin resistance (IR). High Factor VII:C (FVII:C) levels are associated with increased cardiovascular risk and relate to a base change in the FVII gene detected by Msp I endonuclease, and also to an insertion polymorphism in the promoter region. To examine the association between FVII:C levels, genotype and features of IR, 95 NIDDM patients were studied. Genotype was related to FVII:C levels (M1M1 137%, n = 75; M1M2 and M2M2 114%, n = 20, p < 0.005; AA 136%, n = 71; Aa 119%, n = 21, p < 0.05), which is consistent with previous studies in healthy populations. FVII:C correlated with cholesterol (r = 0.51, p < 0.0005), insulin (r = 0.36, p = 0.002), triglycerides (r = 0.34, p = 0.001), age (r = 0.23, p < 0.005) and body mass index (r = 0.23, p < 0.05). When analysed by Msp I genotype, the stronger predictor of FVII:C levels, these correlations remained, with no difference in regression slopes. In a multiple regression model, genotype, cholesterol, insulin, and gender remained as independent predictors of FVII:C levels. In conclusion, FVII:C concentrations are elevated in NIDDM in relation to both FVII genotypes and features of IR.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8701397

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  6 in total

1.  Effects of different protein sources on plasminogen inhibitor-1 and factor VII coagulant activity added to a fat-rich meal in type 2 diabetes.

Authors:  Lene S Mortensen; Claus Thomsen; Kjeld Hermansen
Journal:  Rev Diabet Stud       Date:  2010-11-10

Review 2.  Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies.

Authors:  Christina Voulgari; Dimitrios Papadogiannis; Nicholas Tentolouris
Journal:  Vasc Health Risk Manag       Date:  2010-10-21

Review 3.  Diabetes and cardiovascular disease: pathophysiology of a life-threatening epidemic.

Authors:  R J King; P J Grant
Journal:  Herz       Date:  2016-05       Impact factor: 1.443

4.  Increased atherothrombotic burden in patients with diabetes mellitus and acute coronary syndrome: a review of antiplatelet therapy.

Authors:  Karthik Balasubramaniam; Girish N Viswanathan; Sally M Marshall; Azfar G Zaman
Journal:  Cardiol Res Pract       Date:  2012-01-05       Impact factor: 1.866

5.  Risk of disseminated intravascular coagulation in patients with type 2 diabetes mellitus: retrospective cohort study.

Authors:  Kenichiro Nogami; Isao Muraki; Hironori Imano; Hiroyasu Iso
Journal:  BMJ Open       Date:  2017-01-25       Impact factor: 2.692

Review 6.  Diabetes and atherothrombosis: The circadian rhythm and role of melatonin in vascular protection.

Authors:  Anastasia Otamas; Peter J Grant; Ramzi A Ajjan
Journal:  Diab Vasc Dis Res       Date:  2020 Mar-Apr       Impact factor: 3.291

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.